Connect with us

corporations

Pharmaceutical Biojam says that Infarmed has been analyzing an ACM request for two years

Published

em

Carlos Jorge Monteiro, CEO of Biojam. Photo: DR | Biojam

The Portuguese pharmaceutical company Biojam announced that it intends to place a product on the Portuguese market, but that it has not yet succeeded because Infarmed has been analyzing its application for at least two years. In interview with Jornal Económico, the company's CEO, Carlos Jorge Monteiro, confessed that he has been waiting, since 2021, for a response from Infarmed to the requests for ACM under evaluation. 

A Portuguese pharmaceutical company is preparing to enter the medical cannabis market. This is Biojam, managed by Carlos Jorge Monteiro, who in an interview with Jornal Económico revealed the company's plans for the launch of a new cannabis-based product. However, the road to effective authorization does not seem to be an easy one, according to what he revealed to Jornal Económico. Since 2021, the company has been waiting for feedback from Infarmed regarding an ACM.

Biojam is not yet on the list of companies licensed to operate with controlled substances such as cannabis. The Cannareporter asked Infarmed for clarification on this issue and is awaiting a response.

Manager accuses Infarmed of “lack of knowledge”

In the same newspaper, manager Carlos Jorge Monteiro accuses Infarmed of “lack of knowledge” of the cannabis industry, stating that in 2021 the company would have already submitted the dossier for approval of a new drug. However, the regulator still failed to respond. Monteiro also regrets the lack of preparation in the medicine market for the use of cannabis-based medicines, “due to lack of knowledge and because medicine in Portugal is very conventional, it likes synthetic medicines, produced in the laboratory”, he says.

Biojam's CEO also states that companies that have recently terminated or resized operations in Portugal (Tilray e Clever leaves), may be related to the lack of knowledge of the regulator and the conventional market.”

Cannareporter is also trying to contact Carlos Jorge Monteiro to better understand what ACM he is referring to and what kind of license Biojam has to operate in the sector.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International2 days ago

Paul Bergholts, alleged leader of Juicy Fields, detained in the Dominican Republic

Paul Bergholts, the alleged leader of the Juicy Fields pyramid scheme, has been detained in the Dominican Republic and will be subjected to...

Health5 days ago

Cannabinoids reveal promising results in the treatment of Borderline Personality Disorder

An investigation carried out by Khiron LifeSciences and coordinated by Guillermo Moreno Sanz suggests that medicines based on...

International5 days ago

Juicy Fields case: 9 detained by Europol and Eurojustice. Scam exceeds 645 million euros

A joint investigation conducted by several European authorities, supported by Europol and Eurojust, culminated in the arrest of nine suspects...

International1 weeks ago

Regular cannabis users may require more anesthesia during medical procedures

Regular cannabis users may require more anesthesia during medical procedures to remain sedated compared to...

International1 weeks ago

The future of CBD in Japan: How legal reforms will shape the market

Late last year, Japan took a big step towards cannabis reform after approving...

National1 weeks ago

Portugal: GreenBe Pharma obtains EuGMP certification at Elvas facilities

GreenBe Pharma, a medical cannabis company located in Elvas, Portugal, has obtained EU-GMP certification under...

National2 weeks ago

Álvaro Covões, from Everything is New, buys Clever Leaves facilities in Alentejo for 1.4 million euros

Álvaro Covões, founder and CEO of the show promotion agency 'Everything is New', which organizes one of the biggest festivals in...

Events2 weeks ago

ICBC returns to Berlin on April 16th and 17th

It is one of the largest and most recognized B2B cannabis conferences in Europe and returns to Berlin in...

International2 weeks ago

The legalization of cannabis in Germany seen through the eyes of the hacker who created an essential map

A hacker from Koblenz, a city in the state of Rhineland-Palatinate, created a map with the places where, from...

National2 weeks ago

André Ventura says he wants to “Clean up all cannabis in Portugal”

André Ventura, the well-known leader of the far-right Portuguese political party Chega, has said he wants to “cleanse all cannabis from...